Release Date: 12/07/19 17:23 Summary: Vesting and Lapsing of Performance Rights Price Sensitive: No Download Document 536.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%